ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
TECHBuyZACKSHold
R500#133 today
$262.82
+1.11% today · -0.58% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- ABBV +1.11% on the last session vs SPY +0.74%: +0.4 pts of stock-specific move.
- Aftermath, 52-week high (Sep 28): After its 11 new 52-week highs in the past 5 years, ABBV typically gained 0.8% over the next week (median) and was higher 55% of the time; half the outcomes fell between -1.2% and +3.4%. An ordinary week: +0.5%. Among S&P 500 stocks after new 52-week highs, that ranks #153 of 482.
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 30
Before the open · in 26 days
EPS estimate
$3.84
$3.77 to $3.87 · 19 analysts
Revenue estimate
$17.3B
$17.2B to $17.5B
Track record
7/8 beats
last 8 reports · moved ±3.5% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 BMO | 2Q2026 | $3.61 | $3.65 | +$0.04 (+1.2%) beat | $17.0B | -2.5% -3.2 vs SPY | -1.9% | -5.3% |
| Apr 29, 2026 BMO | 1Q2026 | $2.67 | $2.65 | −$0.02 (−0.8%) miss | $15.0B | +3.1% +3.2 vs SPY | -2.9% | +4.3% |
| Feb 4, 2026 BMO | 4Q2025 | $2.65 | $2.71 | +$0.06 (+2.2%) beat | $16.6B | -3.8% -3.3 vs SPY | -7.0% | -1.4% |
| Oct 31, 2025 BMO | 3Q2025 | $1.78 | $1.86 | +$0.08 (+4.2%) beat | $15.8B | -4.5% -4.8 vs SPY | -2.3% | -4.0% |
| Jul 31, 2025 BMO | $2.91 | $2.97 | +$0.06 (+2.1%) beat | — | -0.1% +0.2 vs SPY | +4.1% | +3.7% | |
| Apr 25, 2025 BMO | $2.40 | $2.46 | +$0.06 (+2.5%) beat | — | +3.1% +2.4 vs SPY | +3.7% | +7.2% | |
| Jan 31, 2025 BMO | $2.12 | $2.16 | +$0.04 (+1.9%) beat | — | +4.7% +5.2 vs SPY | +6.6% | +9.9% | |
| Oct 30, 2024 BMO | $2.92 | $3.00 | +$0.08 (+2.7%) beat | — | +6.4% +6.7 vs SPY | +1.1% | +6.5% | |
| Jul 25, 2024 BMO | $2.66 | $2.65 | −$0.01 (−0.4%) miss | — | +3.4% +3.9 vs SPY | +0.5% | +5.2% | |
| Apr 26, 2024 BMO | $2.26 | $2.31 | +$0.05 (+2.2%) beat | — | -4.6% -5.5 vs SPY | -0.1% | -3.9% | |
| Feb 2, 2024 BMO | $2.80 | $2.79 | −$0.01 (−0.4%) miss | — | +0.6% -0.4 vs SPY | +1.1% | +4.3% | |
| Oct 27, 2023 BMO | $2.87 | $2.95 | +$0.08 (+2.8%) beat | — | -4.3% -3.9 vs SPY | -4.4% | -1.3% | |
| Jul 27, 2023 BMO | $2.81 | $2.91 | +$0.10 (+3.6%) beat | — | +4.9% +5.6 vs SPY | +1.8% | +5.3% | |
| Apr 27, 2023 BMO | $2.49 | $2.46 | −$0.03 (−1.2%) miss | — | -8.0% -10.0 vs SPY | -4.9% | -7.8% | |
| Feb 9, 2023 BMO | $3.58 | $3.60 | +$0.02 (+0.6%) beat | — | +2.8% +3.7 vs SPY | +2.7% | +4.5% | |
| Oct 28, 2022 BMO | $3.57 | $3.66 | +$0.09 (+2.5%) beat | — | -3.8% -6.2 vs SPY | -4.9% | -5.9% | |
| Jul 29, 2022 BMO | $3.31 | $3.37 | +$0.06 (+1.8%) beat | — | -4.2% -5.6 vs SPY | -2.9% | -7.2% | |
| Apr 29, 2022 BMO | $3.14 | $3.16 | +$0.02 (+0.6%) beat | — | -6.0% -2.3 vs SPY | -4.3% | -2.6% | |
| Feb 2, 2022 BMO | $3.28 | $3.31 | +$0.03 (+0.9%) beat | — | +1.2% +0.2 vs SPY | -1.2% | +4.8% | |
| Oct 29, 2021 BMO | $3.22 | $3.33 | +$0.11 (+3.4%) beat | — | +4.6% +4.4 vs SPY | +2.2% | +6.7% | |
| Jul 30, 2021 BMO | $3.03 | $3.11 | +$0.08 (+2.6%) beat | — | — | — | — | |
| Apr 30, 2021 BMO | $2.83 | $2.95 | +$0.12 (+4.2%) beat | — | — | — | — | |
| Feb 3, 2021 BMO | $2.85 | $2.92 | +$0.07 (+2.5%) beat | — | — | — | — | |
| Oct 30, 2020 BMO | $2.77 | $2.83 | +$0.06 (+2.2%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $3.84 (19) | $3.77 – $3.87 | +107% | -0.1% | ▲6 ▼7 | $17.3B | +10% |
| Next quarter · Dec 31, 2026 | $3.86 (18) | $3.77 – $3.98 | +42% | -3.3% | ▲2 ▼0 | $18.3B | +10% |
| Current year · Dec 31, 2026 | $14.01 (26) | $13.90 – $14.12 | +40% | -1.7% | ▲0 ▼1 | $67.6B | +11% |
| Next year · Dec 31, 2027 | $16.26 (25) | $15.13 – $17.59 | +16% | 0.0% | ▲3 ▼1 | $73.5B | +9% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.